Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Inventory Average (2016 - 2025)

Historic Inventory Average for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to $8.2 billion.

  • Gsk's Inventory Average rose 841.38% to $8.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 billion, marking a year-over-year increase of 841.38%. This contributed to the annual value of $7.0 billion for FY2024, which is 664.64% up from last year.
  • Per Gsk's latest filing, its Inventory Average stood at $8.2 billion for Q3 2025, which was up 841.38% from $7.8 billion recorded in Q2 2025.
  • Over the past 5 years, Gsk's Inventory Average peaked at $8.7 billion during Q3 2021, and registered a low of $3.6 billion during Q2 2022.
  • For the 5-year period, Gsk's Inventory Average averaged around $7.0 billion, with its median value being $7.3 billion (2024).
  • Its Inventory Average has fluctuated over the past 5 years, first plummeted by 5868.59% in 2022, then surged by 8629.31% in 2023.
  • Quarter analysis of 5 years shows Gsk's Inventory Average stood at $8.2 billion in 2021, then decreased by 29.73% to $5.8 billion in 2022, then increased by 19.42% to $6.9 billion in 2023, then grew by 8.72% to $7.5 billion in 2024, then increased by 9.28% to $8.2 billion in 2025.
  • Its last three reported values are $8.2 billion in Q3 2025, $7.8 billion for Q2 2025, and $7.4 billion during Q1 2025.